BeOne Medicines (BEIGF) Shareholder's Equity (2015 - 2026)
BeOne Medicines (BEIGF) Shareholder's Equity (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Shareholder's Equity (Qtr) |
| 1 |
Alterity Therapeutics |
821,726.73 Bn |
821,726.69 Bn |
- |
7.14 Bn |
| 2 |
Belite Bio |
57,768.00 Bn |
57,768.00 Bn |
- |
795.79 Mn |
| 3 |
Quantum Biopharma |
16,655.88 Bn |
16,655.88 Bn |
- |
595,226.00 |
| 4 |
Legend Biotech |
3,540.00 Bn |
3,539.71 Bn |
242.10 Mn |
1.00 Bn |
| 5 |
Evaxion A |
1,526.26 Bn |
1,526.24 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,520.09 Bn |
1,520.09 Bn |
- |
14.38 Mn |
| 7 |
Psyence Biomedical |
223.87 Bn |
223.87 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.47 Bn |
107.23 Bn |
2.59 Bn |
19.36 Bn |
| 9 |
Abivax |
91.22 Bn |
91.22 Bn |
- |
502.95 Mn |
| 10 |
BeOne Medicines |
- |
- |
1.35 Bn |
4.76 Bn |
| Date | Value |
| Mar 31, 2026 |
4.76 Bn |
| Dec 31, 2025 |
4.36 Bn |
| Sep 30, 2025 |
4.13 Bn |
| Jun 30, 2025 |
3.77 Bn |
| Mar 31, 2025 |
3.50 Bn |
| Dec 31, 2024 |
3.33 Bn |
| Sep 30, 2024 |
3.44 Bn |
| Jun 30, 2024 |
3.37 Bn |
| Mar 31, 2024 |
3.36 Bn |
| Dec 31, 2023 |
3.54 Bn |
| Sep 30, 2023 |
3.76 Bn |
| Jun 30, 2023 |
3.80 Bn |
| Mar 31, 2023 |
4.16 Bn |
| Dec 31, 2022 |
4.38 Bn |
| Sep 30, 2022 |
4.66 Bn |
| Jun 30, 2022 |
5.20 Bn |
| Mar 31, 2022 |
5.77 Bn |
| Dec 31, 2021 |
6.13 Bn |
| Sep 30, 2021 |
3.36 Bn |
| Jun 30, 2021 |
3.61 Bn |